From a preclinical standpoint, rapamycin-induced inhibition of mTOR in the 3xTg-AD mouse model increased the abundance of autophagy-related proteins, while simultaneously reducing both soluble Aβ and tau levels (Caccamo et al., 2010). This evidence concerns the gene MAPT and Alzheimer disease.